跳至主要内容
临床试验/CTRI/2021/05/033711
CTRI/2021/05/033711已完成2 期

Comparative evaluation of the efficacy of Hydrocortisone suppository and Durvadi Gudavarti in Raktarsha.

Mahatma Gandhi Ayurveda College Hospital Research center Salod Wardha Maharastra0 个研究点目标入组 130 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosed case of Internal Haemorrhoids of grade 2 (Goligher classification) patients (characterized by bleeding PR, anal pain, pile mass/lump of variable size and appearance possibly red-violet/blue color, anal pruritus, mucous discharge and constipation)
  • Patients having hemoglobin more than or equal to 10 gm% & who will give their written, informed consent to participate will be included for the study

排除标准

  • Patient below the age of 20 and above age of 60.
  • Patients having hemoglobin less than 10 gm%.
  • Grade 1, 3 and 4 Haemorrhoids (Goligher classification), external haemorrhoids, external thrombosed haemorrhoids.
  • Haemorrhoids associated with acute Fissure-in-Ano, Fistula in ano, Ulcerative colitis, Crohn’s disease, Malignancy, Intestinal Polyps, Diverticulitis.
  • Patients of TB, Diabetes mellitus and uncontrolled hypertension, portal hypertension, septic or severe hemorrhagic complications, bleeding disorders, acute diarrhea in last 12 hrs, allergy to corticosteroids or any other component of the medicament; on corticosteroids therapy, on anticoagulant medications, on other antihemorrhoidal drugs or planning to undergo any surgical procedure for hemorrhoids. Pregnant & nursing females.
  • HIV and HbsAg positive patients will be excluded from the study.

研究者

发起方
Mahatma Gandhi Ayurveda College Hospital Research center Salod Wardha Maharastra

相似试验

A clinical trial to study the comparative effects of... | 临床试验